Tag: opioid use disorder market outlook

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Opioid Use Disorder (OUD) Market Size Outlook: How Fast Will Revenue Grow Through 2030?

The market for Opioid Use Disorder (OUD) has experienced substantial expansion. Projections indicate a growth from $4.37 billion in 2025 to $4.89 billion in 2026, reflecting a compound annual growth rate of 11.8%. Factors contributing to its expansion during the preceding period include the widespread prescription of opioid analgesics, a rise in the incidence of persistent pain, restricted availability of initial addiction interventions, societal prejudices concerning addiction treatment, and the increasing accessibility of illegal opioids.

Anticipated to expand significantly in the coming years, the opioid use disorder (OUD) market is projected to reach a valuation of $7.82 billion by 2030, driven by a compound annual growth rate (CAGR) of 12.5%. This upward trajectory during the forecast period is bolstered by several key factors, including increased financial contributions from governments towards addiction treatment initiatives, a greater acceptance of medication-assisted treatment, the proliferation of virtual and telehealth services for addiction support, broader insurance coverage for OUD interventions, and a heightened emphasis on strategies aimed at prevention and harm reduction. Furthermore, prominent trends expected to shape the market include a growing embrace of medication-assisted treatment programs, the enhanced combination of behavioral therapy with pharmaceutical treatments, the wider establishment of community-based opioid treatment facilities, a surge in interest for long-acting injectable treatments for OUD, and a more pronounced focus on preventing relapse and supporting sustained recovery.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

Opioid Use Disorder (OUD) Market Growth Drivers: What Factors Are Accelerating Expansion?

The increasing prevalence of opioid addiction is anticipated to fuel the expansion of the opioid use disorder (OUD) market. Opioid addiction, a condition marked by persistent and uncontrolled opioid consumption with detrimental health outcomes, stems from the euphoric and pain-relieving properties of these substances. Sustained use can result in the development of tolerance, necessitating increased dosages for the same effect, which may ultimately lead to opioid use disorder. Illustrating this trend, the Centers for Disease Control and Prevention reported that in 2023, there were 79,358 drug overdose deaths involving any opioid in the United States, translating to 23.7 deaths per 100,000 individuals. Consequently, the rising incidence of opioid addiction is a primary driver for the growth observed in the opioid use disorder (OUD) market.

Opioid Use Disorder (OUD) Market Segment Analysis And Revenue Opportunities

The opioid use disorder (oud) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route Of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

Opioid Use Disorder (OUD) Market Trends: What Is Shaping Future Industry Growth?

The leading businesses within the opioid use disorder (OUD) sector are concentrating their efforts on crafting novel treatments, specifically advanced extended-release buprenorphine formulations, in response to the escalating need for long-duration therapies that aid compliance, alleviate withdrawal phenomena, and enhance recovery achievements. These extended-release buprenorphine products ensure a continuous supply of medication across weekly or monthly periods, presenting superior ease of use and consistent therapeutic levels when contrasted with daily oral or sublingual methods that potentially elevate the likelihood of relapse. A notable development occurred in May 2023 when Brixadi (buprenorphine) extended-release injection received approval from the U.S. Food and Drug Administration, a federal entity in the United States, for the management of moderate to severe opioid use disorder (OUD). Brixadi is offered in two distinct administrations: a weekly injection suitable for individuals initiating treatment with a single dose of a transmucosal buprenorphine product or those currently on the medication, and a monthly option designated for patients already undergoing treatment.

Opioid Use Disorder (OUD) Market Leading Players Shaping Industry Direction

Major companies operating in the opioid use disorder (oud) market are Indivior Plc., Alkermes Inc., Braeburn Pharmaceuticals Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo US Inc., Rhodes Pharmaceuticals L P, Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Mylan NV, Adapt Pharma Inc., Opiant Pharmaceuticals Inc., Dr Reddy’s Laboratories Ltd., Cipla Limited, Luye Pharma Group, Amneal Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Knight Therapeutics, BioCorRx Inc., Lannett Company Inc., Zydus Cadila, Apotex Inc., Intas Biopharmaceuticals, Glenmark Pharmaceuticals Ltd., InterveXion Therapeutics

Access The Complete Opioid Use Disorder (OUD) Market Report:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Opioid Use Disorder (OUD) Market Leading Geography: Which Region Generates The Most Revenue?

North Americawas the largest region in the opioid use disorder (OUD) market in 2025. The regions covered in the opioid use disorder (oud) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Larger Will The Opioid Use Disorder (OUD) Market Become By 2030 Compared To 2026?

The opioid use disorder (oud) market has experienced rapid expansion in recent years. This market is projected to grow from $4.37 billion in 2025 to $4.89 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.8%. The historical growth can be attributed to several factors, including the widespread overprescription of opioid painkillers, an increasing prevalence of chronic pain conditions, limited access to early addiction treatment, the social stigma surrounding substance abuse treatment, and the growing availability of illicit opioids.

The market for opioid use disorder (OUD) is projected to experience substantial growth in the upcoming years, with an anticipated value of $7.82 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.5%. This expansion during the forecast period is fueled by several factors, including increased government investment in addiction treatment initiatives, wider embrace of medication-assisted treatment, the proliferation of online and telehealth services for addiction, broader insurance coverage for OUD treatments, and a greater emphasis on preventive measures and harm reduction approaches. Key trends foreseen over this period involve the growing implementation of medication-assisted treatment programs, enhanced integration of behavioral therapy with pharmaceutical care, the expanding network of community-based opioid treatment facilities, a heightened focus on long-acting injectable OUD therapies, and a stronger emphasis on preventing relapses and ensuring long-term recovery support.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

Which Growth Drivers Are Expected To Support The Opioid Use Disorder (OUD) Market Forward?

The increasing number of opioid addiction cases is anticipated to drive the expansion of the opioid use disorder (OUD) market in the future. Opioid addiction is a medical condition defined by the compulsive and chronic consumption of opioids, which leads to detrimental effects on the body. Opioids offer sensations of euphoria and pain relief, but their persistent use can result in tolerance, where greater doses are needed to achieve the desired effect, potentially leading to opioid use disorder. For instance, in 2023, according to the Centers for Disease Control and Prevention, a US-based public health agency, the number of drug overdose deaths involving any opioid was 79,358. This figure represents 23.7 drug overdose deaths involving any opioid per 100,000 population. Consequently, the rising prevalence of opioid addiction cases fuels the growth of the opioid use disorder (OUD) market.

Which Segment-Based Categories Are Covered In The Opioid Use Disorder (OUD) Market?

The opioid use disorder (oud) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route Of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

Which Trends Are Supporting The Evolution Of The Opioid Use Disorder (OUD) Market?

Which Organizations Are Involved In The Opioid Use Disorder (OUD) Market?

Major companies operating in the opioid use disorder (oud) market are Indivior Plc., Alkermes Inc., Braeburn Pharmaceuticals Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo US Inc., Rhodes Pharmaceuticals L P, Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Mylan NV, Adapt Pharma Inc., Opiant Pharmaceuticals Inc., Dr Reddy’s Laboratories Ltd., Cipla Limited, Luye Pharma Group, Amneal Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Knight Therapeutics, BioCorRx Inc., Lannett Company Inc., Zydus Cadila, Apotex Inc., Intas Biopharmaceuticals, Glenmark Pharmaceuticals Ltd., InterveXion Therapeutics

Access The Complete Opioid Use Disorder (OUD) Market Report:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Which Region Commands The Largest Share Of The Opioid Use Disorder (OUD) Market?

North America was the largest region in the opioid use disorder (OUD) market in 2025. The regions covered in the opioid use disorder (oud) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Opioid Use Disorder (OUD) Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

Browse Through More Reports Similar to the Global Opioid Use Disorder (OUD) Market 2026, By The Business Research Company

Ophthalmic Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report

Ophthalmology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market

Ophthalmic Eye Dropper Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ophthalmic-eye-dropper-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Opioid Use Disorder (OUD) Market In 2026, And How Will Its Value Evolve By 2030?

The market size for opioid use disorder (OUD) has experienced substantial growth in recent years. It is projected to increase from $4.37 billion in 2025 to $4.89 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.8%. Historically, this expansion can be linked to the overprescription of opioid painkillers, the growing prevalence of chronic pain conditions, insufficient access to early addiction treatment, the social stigma associated with substance abuse treatment, and the increased availability of illicit opioids.

The opioid use disorder (oud) market size is projected to experience substantial growth over the coming years, reaching $7.82 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.5%. This projected expansion during the forecast period is primarily driven by factors such as increased government financial support for addiction treatment initiatives, a greater embrace of medication-assisted treatment, the proliferation of online and telehealth services for addiction, broadened insurance coverage for OUD therapies, and a heightened emphasis on strategies for prevention and harm reduction. Key developments anticipated in the forecast period involve a rising uptake of medication-assisted treatment programs, enhanced integration of behavioral therapy with pharmacological interventions, the ongoing expansion of community-based opioid treatment facilities, a growing focus on long-acting injectable treatments for OUD, and an increased commitment to preventing relapse and ensuring long-term recovery care.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What Key Drivers Are Fueling The Growth Of The Opioid Use Disorder (OUD) Market?

An increasing incidence of opioid addiction is anticipated to fuel expansion within the opioid use disorder (OUD) market. This addiction is defined as a chronic medical condition marked by an uncontrollable and persistent reliance on opioids, resulting in detrimental bodily effects. Opioids initially offer feelings of euphoria and pain alleviation, but their ongoing consumption often leads to tolerance, necessitating larger doses for the same impact, ultimately progressing to opioid use disorder. For example, data from the Centers for Disease Control and Prevention, a US public health agency, indicates that in 2023, there were 79,358 drug overdose deaths linked to any opioid. Furthermore, the rate of such deaths was 23.7 per 100,000 population. Consequently, the rising instances of opioid addiction are a key factor driving the growth of the opioid use disorder (OUD) market.

Which Segment Types Are Examined In The Opioid Use Disorder (OUD) Market Segment Study?

The opioid use disorder (oud) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route Of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

What Trends Are Influencing The Opioid Use Disorder (OUD) Market?

Leading companies active in the opioid use disorder (OUD) market are focusing on developing innovative solutions, such as next-generation extended-release buprenorphine formulations, to meet the increasing demand for long-acting, adherence-supportive treatment options that reduce withdrawal symptoms and improve recovery outcomes. Extended-release buprenorphine formulations provide sustained medication delivery over weekly or monthly intervals, offering greater convenience and stability compared with daily oral or sublingual therapies that may increase relapse risk. For instance, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, approved Brixadi (buprenorphine) extended-release injection for the treatment of moderate to severe opioid use disorder (OUD). Brixadi is available in two dosage forms: a weekly injection for patients who initiated treatment with a single dose of a transmucosal buprenorphine product or are currently taking the medication, and a monthly version for those who are already receiving the medication.

Which Players Are Part Of The Competitive Landscape Of The Opioid Use Disorder (OUD) Market?

Major companies operating in the opioid use disorder (oud) market are Indivior Plc., Alkermes Inc., Braeburn Pharmaceuticals Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo US Inc., Rhodes Pharmaceuticals L P, Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Mylan NV, Adapt Pharma Inc., Opiant Pharmaceuticals Inc., Dr Reddy’s Laboratories Ltd., Cipla Limited, Luye Pharma Group, Amneal Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Knight Therapeutics, BioCorRx Inc., Lannett Company Inc., Zydus Cadila, Apotex Inc., Intas Biopharmaceuticals, Glenmark Pharmaceuticals Ltd., InterveXion Therapeutics

Get The Full Opioid Use Disorder (OUD) Market Report:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Where Is The Opioid Use Disorder (OUD) Market Primarily Concentrated By Region?

North America was the largest region in the opioid use disorder (OUD) market in 2025. The regions covered in the opioid use disorder (oud) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Opioid Use Disorder (OUD) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Browse Through More Reports Similar to the Global Opioid Use Disorder (OUD) Market 2026, By The Business Research Company

Ophthalmic Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report

Ophthalmology Drugs Market

https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market

Ophthalmic Eye Dropper Market Report

https://www.thebusinessresearchcompany.com/report/ophthalmic-eye-dropper-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Opioid Use Disorder (OUD) Market Across 2026–2030?

The opioid use disorder (OUD) market has expanded quickly in recent years. It is projected to increase from $4.37 billion in 2025 to $4.89 billion in 2026, with an 11.8% compound annual growth rate (CAGR). This growth observed in the past can be ascribed to several factors, including the overprescription of opioid painkillers, a rising prevalence of chronic pain conditions, restricted access to early addiction treatment, the social stigma associated with substance abuse treatment, and the growing availability of illicit opioids.

The opioid use disorder (OUD) market is expected to experience significant expansion in the next few years, projected to reach $7.82 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.5%. This growth during the forecast period is influenced by several factors, including increased government funding for addiction treatment initiatives, broader acceptance of medication-assisted treatment, the proliferation of online and telehealth addiction services, expanded insurance coverage for OUD therapies, and an intensified focus on preventive and harm reduction strategies. Key trends for the forecast period include the increasing adoption of medication-assisted treatment programs, enhanced integration of behavioral therapy with pharmacological care, the expansion of community-based opioid treatment centers, a rising focus on long-acting injectable therapies for OUD, and a greater emphasis on relapse prevention and long-term recovery support.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What Primary Drivers Are Shaping The Development Of The Opioid Use Disorder (OUD) Market?

The escalating number of opioid addiction cases is projected to stimulate the expansion of the opioid use disorder (OUD) market. Opioid addiction is characterized as a medical condition involving the compulsive and prolonged use of opioids, resulting in adverse bodily effects. Opioids offer sensations of euphoria and pain relief, yet their continuous consumption can lead to the development of tolerance, requiring larger doses for the same impact, which can then progress into opioid use disorder. For example, in 2023, the Centers for Disease Control and Prevention, a US-based public health agency, reported 79,358 drug overdose deaths involving any opioid. The rate of drug overdose deaths involving any opioid per 100,000 population was 23.7. Thus, the increasing frequency of opioid addiction cases is a key driver for the growth of the opioid use disorder (OUD) market.

What Segmentation Levels Are Considered In The Opioid Use Disorder (OUD) Market?

The opioid use disorder (oud) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route Of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

Which Market Trends Are Creating New Opportunities In The Opioid Use Disorder (OUD) Market?

Companies prominent in the opioid use disorder (OUD) market are prioritizing the creation of innovative solutions, such as advanced extended-release buprenorphine formulations. This effort is in response to the increasing demand for long-acting, adherence-promoting treatment alternatives that alleviate withdrawal symptoms and enhance recovery results. Extended-release buprenorphine formulations offer continuous medication delivery for weekly or monthly durations, providing enhanced convenience and stability compared to daily oral or sublingual therapies, which could potentially raise the risk of relapse. For example, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, granted approval to Brixadi (buprenorphine) extended-release injection for addressing moderate to severe opioid use disorder (OUD). Brixadi is supplied in two forms: a weekly injection for patients who started treatment with a single dose of a transmucosal buprenorphine product or are currently using the medication, and a monthly version for individuals already receiving the drug.

Which Leading Firms Are Contributing To The Growth Of The Opioid Use Disorder (OUD) Market?

Major companies operating in the opioid use disorder (oud) market are Indivior Plc., Alkermes Inc., Braeburn Pharmaceuticals Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo US Inc., Rhodes Pharmaceuticals L P, Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Mylan NV, Adapt Pharma Inc., Opiant Pharmaceuticals Inc., Dr Reddy’s Laboratories Ltd., Cipla Limited, Luye Pharma Group, Amneal Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Knight Therapeutics, BioCorRx Inc., Lannett Company Inc., Zydus Cadila, Apotex Inc., Intas Biopharmaceuticals, Glenmark Pharmaceuticals Ltd., InterveXion Therapeutics

Read the full opioid use disorder (oud) market report here:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

How Does The Opioid Use Disorder (OUD) Market Perform Across Major Global Regions?

North America was the largest region in the opioid use disorder (OUD) market in 2025. The regions covered in the opioid use disorder (oud) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Opioid Use Disorder (OUD) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

Browse Through More Reports Similar to the Global Opioid Use Disorder (OUD) Market 2026, By The Business Research Company

Ophthalmic Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report

Ophthalmology Drugs Market

https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market

Ophthalmic Eye Dropper Global Market Report

https://www.thebusinessresearchcompany.com/report/ophthalmic-eye-dropper-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Opioid Use Disorder (OUD) Market Across 2026–2030?

The opioid use disorder (OUD) market has expanded quickly in recent years. It is projected to increase from $4.37 billion in 2025 to $4.89 billion in 2026, with an 11.8% compound annual growth rate (CAGR). This growth observed in the past can be ascribed to several factors, including the overprescription of opioid painkillers, a rising prevalence of chronic pain conditions, restricted access to early addiction treatment, the social stigma associated with substance abuse treatment, and the growing availability of illicit opioids.

The opioid use disorder (OUD) market is expected to experience significant expansion in the next few years, projected to reach $7.82 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.5%. This growth during the forecast period is influenced by several factors, including increased government funding for addiction treatment initiatives, broader acceptance of medication-assisted treatment, the proliferation of online and telehealth addiction services, expanded insurance coverage for OUD therapies, and an intensified focus on preventive and harm reduction strategies. Key trends for the forecast period include the increasing adoption of medication-assisted treatment programs, enhanced integration of behavioral therapy with pharmacological care, the expansion of community-based opioid treatment centers, a rising focus on long-acting injectable therapies for OUD, and a greater emphasis on relapse prevention and long-term recovery support.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What Primary Drivers Are Shaping The Development Of The Opioid Use Disorder (OUD) Market?

The escalating number of opioid addiction cases is projected to stimulate the expansion of the opioid use disorder (OUD) market. Opioid addiction is characterized as a medical condition involving the compulsive and prolonged use of opioids, resulting in adverse bodily effects. Opioids offer sensations of euphoria and pain relief, yet their continuous consumption can lead to the development of tolerance, requiring larger doses for the same impact, which can then progress into opioid use disorder. For example, in 2023, the Centers for Disease Control and Prevention, a US-based public health agency, reported 79,358 drug overdose deaths involving any opioid. The rate of drug overdose deaths involving any opioid per 100,000 population was 23.7. Thus, the increasing frequency of opioid addiction cases is a key driver for the growth of the opioid use disorder (OUD) market.

What Segmentation Levels Are Considered In The Opioid Use Disorder (OUD) Market?

The opioid use disorder (oud) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route Of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

Which Market Trends Are Creating New Opportunities In The Opioid Use Disorder (OUD) Market?

Companies prominent in the opioid use disorder (OUD) market are prioritizing the creation of innovative solutions, such as advanced extended-release buprenorphine formulations. This effort is in response to the increasing demand for long-acting, adherence-promoting treatment alternatives that alleviate withdrawal symptoms and enhance recovery results. Extended-release buprenorphine formulations offer continuous medication delivery for weekly or monthly durations, providing enhanced convenience and stability compared to daily oral or sublingual therapies, which could potentially raise the risk of relapse. For example, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, granted approval to Brixadi (buprenorphine) extended-release injection for addressing moderate to severe opioid use disorder (OUD). Brixadi is supplied in two forms: a weekly injection for patients who started treatment with a single dose of a transmucosal buprenorphine product or are currently using the medication, and a monthly version for individuals already receiving the drug.

Which Leading Firms Are Contributing To The Growth Of The Opioid Use Disorder (OUD) Market?

Major companies operating in the opioid use disorder (oud) market are Indivior Plc., Alkermes Inc., Braeburn Pharmaceuticals Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo US Inc., Rhodes Pharmaceuticals L P, Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Mylan NV, Adapt Pharma Inc., Opiant Pharmaceuticals Inc., Dr Reddy’s Laboratories Ltd., Cipla Limited, Luye Pharma Group, Amneal Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Knight Therapeutics, BioCorRx Inc., Lannett Company Inc., Zydus Cadila, Apotex Inc., Intas Biopharmaceuticals, Glenmark Pharmaceuticals Ltd., InterveXion Therapeutics

Read the full opioid use disorder (oud) market report here:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

How Does The Opioid Use Disorder (OUD) Market Perform Across Major Global Regions?

North America was the largest region in the opioid use disorder (OUD) market in 2025. The regions covered in the opioid use disorder (oud) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Opioid Use Disorder (OUD) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

Browse Through More Reports Similar to the Global Opioid Use Disorder (OUD) Market 2026, By The Business Research Company

Ophthalmic Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report

Ophthalmology Drugs Market

https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market

Ophthalmic Eye Dropper Global Market Report

https://www.thebusinessresearchcompany.com/report/ophthalmic-eye-dropper-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Opioid Use Disorder (OUD) Market Across 2026–2030?

The opioid use disorder (OUD) market has expanded quickly in recent years. It is projected to increase from $4.37 billion in 2025 to $4.89 billion in 2026, with an 11.8% compound annual growth rate (CAGR). This growth observed in the past can be ascribed to several factors, including the overprescription of opioid painkillers, a rising prevalence of chronic pain conditions, restricted access to early addiction treatment, the social stigma associated with substance abuse treatment, and the growing availability of illicit opioids.

The opioid use disorder (OUD) market is expected to experience significant expansion in the next few years, projected to reach $7.82 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.5%. This growth during the forecast period is influenced by several factors, including increased government funding for addiction treatment initiatives, broader acceptance of medication-assisted treatment, the proliferation of online and telehealth addiction services, expanded insurance coverage for OUD therapies, and an intensified focus on preventive and harm reduction strategies. Key trends for the forecast period include the increasing adoption of medication-assisted treatment programs, enhanced integration of behavioral therapy with pharmacological care, the expansion of community-based opioid treatment centers, a rising focus on long-acting injectable therapies for OUD, and a greater emphasis on relapse prevention and long-term recovery support.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What Primary Drivers Are Shaping The Development Of The Opioid Use Disorder (OUD) Market?

The escalating number of opioid addiction cases is projected to stimulate the expansion of the opioid use disorder (OUD) market. Opioid addiction is characterized as a medical condition involving the compulsive and prolonged use of opioids, resulting in adverse bodily effects. Opioids offer sensations of euphoria and pain relief, yet their continuous consumption can lead to the development of tolerance, requiring larger doses for the same impact, which can then progress into opioid use disorder. For example, in 2023, the Centers for Disease Control and Prevention, a US-based public health agency, reported 79,358 drug overdose deaths involving any opioid. The rate of drug overdose deaths involving any opioid per 100,000 population was 23.7. Thus, the increasing frequency of opioid addiction cases is a key driver for the growth of the opioid use disorder (OUD) market.

What Segmentation Levels Are Considered In The Opioid Use Disorder (OUD) Market?

The opioid use disorder (oud) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route Of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

Which Market Trends Are Creating New Opportunities In The Opioid Use Disorder (OUD) Market?

Companies prominent in the opioid use disorder (OUD) market are prioritizing the creation of innovative solutions, such as advanced extended-release buprenorphine formulations. This effort is in response to the increasing demand for long-acting, adherence-promoting treatment alternatives that alleviate withdrawal symptoms and enhance recovery results. Extended-release buprenorphine formulations offer continuous medication delivery for weekly or monthly durations, providing enhanced convenience and stability compared to daily oral or sublingual therapies, which could potentially raise the risk of relapse. For example, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, granted approval to Brixadi (buprenorphine) extended-release injection for addressing moderate to severe opioid use disorder (OUD). Brixadi is supplied in two forms: a weekly injection for patients who started treatment with a single dose of a transmucosal buprenorphine product or are currently using the medication, and a monthly version for individuals already receiving the drug.

Which Leading Firms Are Contributing To The Growth Of The Opioid Use Disorder (OUD) Market?

Major companies operating in the opioid use disorder (oud) market are Indivior Plc., Alkermes Inc., Braeburn Pharmaceuticals Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo US Inc., Rhodes Pharmaceuticals L P, Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Mylan NV, Adapt Pharma Inc., Opiant Pharmaceuticals Inc., Dr Reddy’s Laboratories Ltd., Cipla Limited, Luye Pharma Group, Amneal Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Knight Therapeutics, BioCorRx Inc., Lannett Company Inc., Zydus Cadila, Apotex Inc., Intas Biopharmaceuticals, Glenmark Pharmaceuticals Ltd., InterveXion Therapeutics

Read the full opioid use disorder (oud) market report here:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

How Does The Opioid Use Disorder (OUD) Market Perform Across Major Global Regions?

North America was the largest region in the opioid use disorder (OUD) market in 2025. The regions covered in the opioid use disorder (oud) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Opioid Use Disorder (OUD) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

Browse Through More Reports Similar to the Global Opioid Use Disorder (OUD) Market 2026, By The Business Research Company

Ophthalmic Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report

Ophthalmology Drugs Market

https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market

Ophthalmic Eye Dropper Global Market Report

https://www.thebusinessresearchcompany.com/report/ophthalmic-eye-dropper-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the opioid use disorder (oud) market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Opioid Use Disorder (OUD) Market expected to reach by 2030?

The market size for opioid use disorder (OUD) has experienced substantial growth in recent years. This market is expected to increase from $4.37 billion in 2025 to $4.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.8%. The reasons for its historical expansion include the overprescription of opioid painkillers, an increasing prevalence of chronic pain conditions, limited access to early addiction treatment, the social stigma surrounding substance abuse treatment, and the growing availability of illicit opioids.

The opioid use disorder (OUD) market is projected to experience substantial expansion over the upcoming years, with an anticipated growth to $7.82 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.5%. This expansion during the forecast period can be attributed to enhanced government investment in addiction treatment initiatives, broader acceptance of medication-assisted treatment, the expansion of online and telehealth services for addiction, increased insurance coverage for OUD treatments, and a heightened emphasis on strategies for prevention and harm reduction. Key trends emerging in this period involve the increasing uptake of medication-assisted treatment programs, a greater integration of behavioral therapy with medication-based care, the proliferation of community-based opioid treatment facilities, a stronger focus on long-acting injectable treatments for OUD, and an amplified commitment to preventing relapse and supporting long-term recovery.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What Drivers Are Driving Adoption Within The Opioid Use Disorder (OUD) Market?

The increasing prevalence of opioid addiction is anticipated to drive the expansion of the opioid use disorder (OUD) market in the future. Opioid addiction is defined as a medical condition marked by habitual and persistent opioid consumption, leading to detrimental bodily effects. Opioids are capable of inducing euphoria and alleviating pain; however, their ongoing use can result in tolerance, necessitating larger doses for the desired effect, potentially culminating in opioid use disorder. For instance, in 2023, according to the Centers for Disease Control and Prevention, a US-based public health agency, in 2023, the number of drug overdose deaths involving any opioid was 79,358. The rate of drug overdose fatalities linked to any opioid stood at 23.7 per 100,000 population. Consequently, the increasing incidence of opioid addiction is a key factor propelling the expansion of the opioid use disorder (OUD) market.

What Segments Are Included Within The Opioid Use Disorder (OUD) Market?

The opioid use disorder (oud) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route Of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

What Trends Are Reshaping The Dynamics Of The Opioid Use Disorder (OUD) Market?

Companies operating within the opioid use disorder (OUD) market are concentrating on developing advanced solutions, such as next-generation extended-release buprenorphine formulations. This focus aims to address the increasing need for long-acting, adherence-supporting treatment options that effectively reduce withdrawal symptoms and enhance recovery outcomes. Extended-release buprenorphine formulations deliver sustained medication over weekly or monthly periods, providing increased convenience and stability compared to daily oral or sublingual therapies, which can elevate the risk of relapse. For instance, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, granted approval to Brixadi (buprenorphine) extended-release injection for treating moderate to severe opioid use disorder (OUD). Brixadi is available in two forms: a weekly injection for patients who started treatment with a single dose of a transmucosal buprenorphine product or are currently taking the medication, and a monthly version for individuals who are already receiving the medication.

Who Are The Top-Performing Companies In The Opioid Use Disorder (OUD) Market In Recent Years?

Major companies operating in the opioid use disorder (oud) market are Indivior Plc., Alkermes Inc., Braeburn Pharmaceuticals Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo US Inc., Rhodes Pharmaceuticals L P, Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Mylan NV, Adapt Pharma Inc., Opiant Pharmaceuticals Inc., Dr Reddy’s Laboratories Ltd., Cipla Limited, Luye Pharma Group, Amneal Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Knight Therapeutics, BioCorRx Inc., Lannett Company Inc., Zydus Cadila, Apotex Inc., Intas Biopharmaceuticals, Glenmark Pharmaceuticals Ltd., InterveXion Therapeutics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

How Does The Opioid Use Disorder (OUD) Market Perform Across Major Global Regions?

North America was the largest region in the opioid use disorder (OUD) market in 2025. The regions covered in the opioid use disorder (oud) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Opioid Use Disorder (OUD) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

Browse Through More Reports Similar to the Global Opioid Use Disorder (OUD) Market 2026, By The Business Research Company

Migraine Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Opioids Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Opioid Induced Constipation Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-induced-constipation-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model